CSF2 and neutropenia: On admission for the fourth cycle of chemotherapy, the patient developed prolonged neutropenia requiring granulocyte macrophage colony-stimulating factor injection (GM-CSF); therefore, the duration of intravenous azacitadine was reduced to five days per cycle.